Clinical Trial Update: A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan) [Phase 2]

View source ↗

Summary

A Phase 2 pivotal subjective sleep study evaluating a nasal dilator (Breathe Right Tan) sponsored by GlaxoSmithKline has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congestion
• Nasal Congestion

Drugs mentioned

• Breathe Right Tan

Snippet

Sponsor: GlaxoSmithKline | Conditions: Congestion, Nasal | Phase 2 | Status: COMPLETED | Results posted: 2018-09-25